1. Khadem A. Building regulatory capacity in countries to improve the regulation of health products. 2018. www.who.int/medicines/technical_briefing/tbs/TBS2018_RSS_Capacity_Building_CRSgroup.pdf.
2. National Academy of Sciences. Regulating medicines in a globalized world: the need for increased reliance among regulators. National Academies Press. 2019. www.nap.edu/catalog/25594/regulating-medicines-in-a-globalized-world-the-need-for-increased.
3. WHO. Development of the roadmap on access to medicines and vaccines 2019-2023. 2020. https://apps.who.int/iris/bitstream/handle/10665/330145/9789241517034-eng.pdf.
4. European Medicines Agency. Conditional marketing authorisation: report on ten years of experience at the European Medicines Agency. www.ema.europa.eu/en/documents/report/conditional-marketing-authorisation-report-ten-years-experience-european-medicines-agency_en.pdf.
5. US Food and Drug Administration. Emergency use authorization. www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization.